STRATEC SE

Director's Dealing • Nov 12, 2010

News Details

Directors’ Dealings | 12 November 2010 20:20

DGAP-DD: STRATEC Biomedical Systems AG english

Notification concerning transactions by persons performing managerial responsibilities pursuant to section 15a of the WpHG Directors’ Dealings notification transmitted by DGAP – a company of EquityStory AG. The person with duty of notification is solely responsible for the content of this announcement. ————————————————————————— Details of the person subject to the disclosure requirement Last name: Leistner First name: Hermann Position: Member of a managing body Information about the transaction with duty of notification Description of the financial instrument: STRATEC Biomedical Systems AG / Ordinary Share ISIN/WKN of the financial instrument: DE0007289001 Type of transaction: Sale Date: 11.11.2010 Price: 27.33 Currency: EUR No. of items: 32500 Total amount traded: 888225.00 Place: außerbörslich / OTC Explanation for publication: Cashless exercise (exercising of stock options incl. block sale of stocks to investor via bank; strike price for underlying stock options: Euro 11.98 and Euro 22.69) Information about the company with duty of publication Issuer: STRATEC Biomedical Systems AG Gewerbestraße 37 75217 Birkenfeld Deutschland ISIN: DE0007289001 WKN: 728900 End of Directors’ Dealings Notification (c) DGAP 12.11.2010 DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de ID 12224